Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05737056
Other study ID # GHRMSA 1278
Secondary ID 2022-A02687-36
Status Completed
Phase
First received
Last updated
Start date May 9, 2023
Est. completion date July 28, 2023

Study information

Verified date October 2023
Source Groupe Hospitalier de la Region de Mulhouse et Sud Alsace
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The main objective of this study is to describe the management of children with rheumatoid purpura from admission to the pediatric emergency room to follow-up by primary care physicians after hospital discharge.


Description:

Secondary objectives The secondary objective is to assess general practitioners current knowledge and practice of the condition and potential barriers to monitoring and follow-up by general practitioners. Conduct of research Children diagnosed with rheumatoid purpura within the past 2 years at the 3 participating sites will be included in the study if parental authority holders do not object. Patients will be identified through the Medical Information Department of each hospital. Parents will be contacted - first by mail, then by phone - to request permission to collect the child's medical data from medical records, and to retrieve information on the surveillance and follow-up of the disease by general practitioners up to two years after diagnosis.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date July 28, 2023
Est. primary completion date July 28, 2023
Accepts healthy volunteers No
Gender All
Age group 0 Years to 18 Years
Eligibility Inclusion Criteria: - Underaged patient diagnosed with rheumatoid purpura during a visit to the pediatric emergencies of Mulhouse, Colmar and Strasbourg - No objection to the study from the two holders of parental authority Exclusion Criteria: - Patient followed in the context of a genetic or malformative pathology, an immune deficiency, or a cancer

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Management of rheumatoid purpura
Collection of data on the management in pediatric emergency departments (method of diagnosis, complementary examinations, proposed treatment, number of hospitalizations, follow-up after hospital discharge).

Locations

Country Name City State
France Hôpitaux Civils de Colmar Colmar
France Hôpital de Hautepierre Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compliance with the recommendations for the management of rheumatoid purpura Up to two years after hospital discharge
Secondary Knowledge assessment questionnaire regarding rheumatoid purpura Evaluation of the knowledge and current practices of general practitioners regarding rheumatoid purpura and identification of the possible obstacles to management and follow-up in primary care, using an online survey At the beginning of the study
See also
  Status Clinical Trial Phase
Completed NCT04655378 - Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura